PRESS RELEASE published on 02/28/2025 at 07:30, 1 year 7 months ago LR Health & Beauty SE achieves significant sales growth in the final quarter of 2024 and meets the sales and earnings forecast for the full year 2024 LR Health & Beauty SE reports significant sales growth of 8.0% in Q4 2024, reaching EUR 76.5 million. Full-year sales at EUR 289.2 million, meeting forecasts. Positive momentum from new products and realigned career plan Earnings Forecast Sales Growth LR Health & Beauty SE Product Launches Q4 2024
BRIEF published on 02/26/2025 at 15:35, 1 year 7 months ago LR Health & Beauty SE Seeks Nasdaq Stockholm Bond Listing Bond Prospectus Nasdaq Stockholm Financial Strategy Investor Information Corporate Bonds
BRIEF published on 02/26/2025 at 15:35, 1 year 7 months ago LR Health & Beauty SE cherche à s'introduire en bourse sur le Nasdaq Stockholm Stratégie Financière Nasdaq Stockholm Informations Pour Les Investisseurs Obligations D'entreprises Prospectus D'obligations
PRESS RELEASE published on 02/26/2025 at 15:30, 1 year 7 months ago LR Health & Beauty SE publishes bond prospectus and applies for admission to trading of bonds on the corporate bond list of Nasdaq Stockholm LR Health & Beauty SE publishes bond prospectus and applies for trading of bonds on Nasdaq Stockholm's corporate bond list; LR Group's holistic business model and commitment to sustainability showcased Sustainability Bond Prospectus Nasdaq Stockholm LR Health & Beauty LR Group
BRIEF published on 11/26/2024 at 12:52, 1 year 10 months ago LR Health & Beauty SE Sees Growth in Q3 2024 EBITDA Forecast LR Health & Beauty Third Quarter Growth 2024 Sales Increase Distributor Strategy
BRIEF published on 11/26/2024 at 12:52, 1 year 10 months ago LR Health & Beauty SE enregistre une croissance au troisième trimestre 2024 LR Santé & Beauté Croissance Au Troisième Trimestre Prévision De L'EBITDA Augmentation Des Ventes En 2024 Stratégie De Distribution
BRIEF published on 11/26/2024 at 12:50, 1 year 10 months ago LR Health & Beauty SE Adjusts 2024 Financial Forecasts Amid Sales Growth Financial Performance 2024 Forecast Adjustment Q3 Sales Growth EBITDA Changes Distributor Realignment
BRIEF published on 11/26/2024 at 12:50, 1 year 10 months ago LR Health & Beauty SE ajuste ses prévisions financières pour 2024 en raison de la croissance des ventes Performance Financière Croissance Des Ventes Au 3e Trimestre Ajustement Des Prévisions Pour 2024 Évolution De L'EBITDA Réalignement Des Distributeurs
PRESS RELEASE published on 11/26/2024 at 12:47, 1 year 10 months ago LR Health & Beauty SE further increases growth trend in the third quarter LR Health & Beauty SE reports 7.2% sales growth in Q3 2024, with EBITDA rising. LR ZEITGARD Signature boosts sales. Adjusted guidance for 2024: Sales range EUR 288M to EUR 292M, EBITDA EUR 26M to EUR 29M EBITDA Sales Growth Financial Forecast LR Health & Beauty SE LR ZEITGARD Signature
PRESS RELEASE published on 11/26/2024 at 12:45, 1 year 10 months ago EQS-Adhoc: LR Health & Beauty SE: Publication of figures for the third quarter of 2024 and adjustment of the forecast for the 2024 financial year LR Health & Beauty SE reports increase in sales for Q3 2024, adjusts forecast for full year. Sales guidance raised to EUR 288-292 million, EBITDA forecast revised to EUR 26-29 million Forecast Adjustment EBITDA Forecast Sales Increase LR Health & Beauty SE 2024 Financial Year
Published on 09/29/2026 at 10:30, 55 minutes ago Preliminary Results of Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofelemer Accepted for Presentation at Annual American College of Gastroenterology Meeting
Published on 09/29/2026 at 09:01, 2 hours 24 minutes ago Star Copper Advances Western Extension Drilling at Star Main
Published on 09/29/2026 at 06:45, 4 hours 40 minutes ago Akkodis and Biolevate Partner to Accelerate AI-Powered Scientific, Regulatory and Technical Documentation in Highly Regulated Industries
Published on 09/29/2026 at 04:36, 6 hours 49 minutes ago The Next Decade of Medical AI: How Humans and AI Collaborate - A Conversation Between Kevin Kelly and Dr. Ning Song of Diagens Tech (2526. HK)
Published on 09/29/2026 at 02:30, 8 hours 55 minutes ago QNX and neueHCT Join Forces to Accelerate Global Intelligent Driving Deployment, Anchored by Major German Automaker Program Win
Published on 09/29/2026 at 11:15, 9 minutes ago EQS-Adhoc: Nakiki SE: NAKIKI SE acquires 9.749% of ecrop GmbH
Published on 09/29/2026 at 11:05, 20 minutes ago Furniture China and Maison Shanghai 2026 Conclude on a High Note in Pudong, Shanghai
Published on 09/29/2026 at 10:05, 1 hour 20 minutes ago LionVolt opens Flight One early access to UAV OEMs
Published on 09/29/2026 at 10:00, 1 hour 25 minutes ago Cyprumed‘s Oral Delivery Technology Advances to Clinical Stage as MSD Initiates Phase I Trial
Published on 09/29/2026 at 09:50, 1 hour 34 minutes ago thyssenkrupp nucera Secures New Chlor-Alkali Order From Hongniu Lanzhou in China
Published on 09/29/2026 at 08:45, 2 hours 40 minutes ago Cegedim Santé réinvente l’accès à l’information médicale en déployant l’Assistant by Claude Bernard IA sur toutes ses solutions de médecine de ville
Published on 09/28/2026 at 17:54, 17 hours 30 minutes ago Reporting on share buyback transactions carried out between September 21 and September 25, 2026
Published on 09/28/2026 at 17:54, 17 hours 30 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 21 et le 25 septembre 2026
Published on 09/28/2026 at 17:45, 17 hours 40 minutes ago Déclaration hebdomadaire de rachat d'actions